OpenURL Connection Search

Select item for more details and to access through your institution.

Establishment and Characterisation by Expression Microarray of Patient-Derived Xenograft Panel of Human Pancreatic Adenocarcinoma Patients.
Published in:
International Journal of Molecular Sciences, 2020, v. 21, n. 3, p. 962, doi. 10.3390/ijms21030962
By:
- Roche, Sandra;
- O'Neill, Fiona;
- Murphy, Jean;
- Swan, Niall;
- Meiller, Justine;
- Conlon, Neil T.;
- Geoghegan, Justin;
- Conlon, Kevin;
- McDermott, Ray;
- Rahman, Rozana;
- Toomey, Sinead;
- Straubinger, Ninfa L.;
- Straubinger, Robert M.;
- O'Connor, Robert;
- McVey, Gerard;
- Moriarty, Michael;
- Clynes, Martin
Publication type:
Article
Alteration in Levels of Specific miRNAs and Their Potential Protein Targets between Human Pancreatic Cancer Samples, Adjacent Normal Tissue, and Xenografts Derived from These Tumors.
Published in:
Life (2075-1729), 2023, v. 13, n. 3, p. 608, doi. 10.3390/life13030608
By:
- O'Neill, Fiona;
- Allen-Coyle, Taylor-Jade;
- Roche, Sandra;
- Meiller, Justine;
- Conlon, Neil T.;
- Swan, Niall;
- Straubinger, Robert M.;
- Geoghegan, Justin;
- Straubinger, Ninfa L.;
- Conlon, Kevin;
- McDermott, Ray;
- O'Sullivan, Finbarr;
- Henry, Michael;
- Meleady, Paula;
- McVey, Gerard;
- O'Connor, Robert;
- Moriarty, Michael;
- Clynes, Martin
Publication type:
Article
A Comparative Quantitative LC-MS/MS Profiling Analysis of Human Pancreatic Adenocarcinoma, Adjacent-Normal Tissue, and Patient-Derived Tumour Xenografts.
Published in:
Proteomes, 2018, v. 6, n. 4, p. 45, doi. 10.3390/proteomes6040045
By:
- Coleman, Orla;
- Henry, Michael;
- O'Neill, Fiona;
- Roche, Sandra;
- Swan, Niall;
- Boyle, Lorraine;
- Murphy, Jean;
- Meiller, Justine;
- Conlon, Neil T.;
- Geoghegan, Justin;
- Conlon, Kevin C.;
- Lynch, Vincent;
- Straubinger, Ninfa L.;
- Straubinger, Robert M.;
- McVey, Gerard;
- Moriarty, Michael;
- Meleady, Paula;
- Clynes, Martin
Publication type:
Article
Controlled coupling of an ultrapotent auristatin warhead to cetuximab yields a next-generation antibody-drug conjugate for EGFR-targeted therapy of KRAS mutant pancreatic cancer.
Published in:
2020
By:
- Greene, Michelle K.;
- Chen, Ting;
- Robinson, Eifion;
- Straubinger, Ninfa L.;
- Minx, Charlene;
- Chan, Darren K. W.;
- Wang, Jun;
- Burrows, James F.;
- Van Schaeybroeck, Sandra;
- Baker, James R.;
- Caddick, Stephen;
- Longley, Daniel B.;
- Mager, Donald E.;
- Straubinger, Robert M.;
- Chudasama, Vijay;
- Scott, Christopher J.
Publication type:
journal article

Found: 4

Establishment and Characterisation by Expression Microarray of Patient-Derived Xenograft Panel of Human Pancreatic Adenocarcinoma Patients.

Alteration in Levels of Specific miRNAs and Their Potential Protein Targets between Human Pancreatic Cancer Samples, Adjacent Normal Tissue, and Xenografts Derived from These Tumors.

A Comparative Quantitative LC-MS/MS Profiling Analysis of Human Pancreatic Adenocarcinoma, Adjacent-Normal Tissue, and Patient-Derived Tumour Xenografts.

Controlled coupling of an ultrapotent auristatin warhead to cetuximab yields a next-generation antibody-drug conjugate for EGFR-targeted therapy of KRAS mutant pancreatic cancer.